Why Las Vegas Sands Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Benzinga04-18

Shares of Las Vegas Sands Corp. (NYSE:LVS) fell sharply during Thursday's session despite better-than-expected first-quarter results.

The company reported quarterly adjusted earnings of 75 cents per share which beat the analyst consensus estimate of 62 cents and represented a 167.86% increase from the same period last year. Quarterly sales clocked in at $2.96 billion which beat the analyst consensus estimate of $2.94 billion and is a 39.58% increase over sales of $2.12 billion from the same quarter last year, according to data from Benzinga Pro.

Las Vegas Sands shares dipped 6.8% to $46.81 on Thursday.

Here are some other stocks moving in today’s mid-day session.

Gainers

  • AGBA Group Holding Limited (NASDAQ:AGBA) shares jumped 148% to $0.9898 after the company announced it entered into a definitive merger agreement with Triller.
  • Tian Ruixiang Holdings Ltd (NASDAQ:TIRX) jumped 106% to $1.0012 after gaining around 8% on Wednesday.
  • Bio-Path Holdings, Inc. (NASDAQ:BPTH) gained 77.7% to $5.74 after the company announced the completion of its second dose cohort in Phase 1/1b clinical trial of BP1002 evaluating the ability of BP1002 to treat refractory/relapsed acute myeloid leukemia patients.
  • Sintx Technologies, Inc. (NASDAQ:SINT) rose 51% to $0.0560.
  • 23andMe Holding Co. (NASDAQ:ME) gained 44% to $0.5035 after CEO Anne Wojcicki said she is considering a proposal to take the company private.
  • Expion360 Inc. (NASDAQ:XPON) gained 42.5% to $2.75. Expion360 announced ‘substantial’ preorders of its Group 27 and GC2 now featuring Vertical Heat Conduction™ Heating Technology.
  • Vertex Energy, Inc. (NASDAQ:VTNR) rose 31% to $1.2901.
  • Aileron Therapeutics, Inc. (NASDAQ:ALRN) jumped 29.4% to $5.50. Ladenburg Thalmann analyst Aydin Huseynov maintained Aileron Therapeutics with a Buy and raised the price target from $9 to $19.
  • MicroCloud Hologram Inc. (NASDAQ:HOLO) gained 26.5% to $2.8350.
  • TH International Limited (NASDAQ:THCH) shares surged 26.4% to $1.3190 after the company reported a year-over-year increase in fourth-quarter financial results.
  • Tiziana Life Sciences Ltd (NASDAQ:TLSA) gained 20.1% to $0.6160. Tiziana Life Sciences announced new quantitative PET imaging data on Foralumab at Meeting of American Academy of Neurology.
  • Smith Micro Software, Inc. (NASDAQ:SMSI) climbed 18.7% to $2.3150.
  • Warrantee Inc. (NASDAQ:WRNT) rose 15.8% to $0.3745.
  • Badger Meter, Inc. (NYSE:BMI) gained 11.8% to $171.06 after the company reported better-than-expected first-quarter results.
  • Genuine Parts Company (NASDAQ:GPC) rose 11.1% to $160.05 after the company reported a first-quarter EPS beat and raised its FY24 guidance.
  • Barnes Group Inc. (NYSE:B) gained 8.8% to $36.31. DA Davidson analyst Matt Summerville upgraded Barnes from Neutral to Buy and raised the price target from $35 to $45.
  • Apogee Enterprises, Inc. (NASDAQ:APOG) climbed 8.1% to $60.42 following upbeat quarterly earnings.

Losers

  • iLearningEngines Holdings, Inc. (NASDAQ:AILE) shares dipped 29.8% to $7.02.
  • SuperCom Ltd. (NASDAQ:SPCB) fell 28.4% to $0.2574. SuperCom announced pricing of $2.9 million registered direct offering.
  • Edible Garden AG Incorporated (NASDAQ:EDBL) shares fell 28.6% to $4.75. Edible Garden recently reported a year-over-year increase in preliminary first-quarter revenues.
  • Lithium Americas Corp. (NYSE:LAC) fell 28% to $4.7750 after the company priced a $275 million public offering.
  • Beneficient (NASDAQ:BENF) fell 27.5% to $4.1920.
  • NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) fell 27.1% to $3.04. NRx Pharmaceuticals announced pricing of $2 million underwritten public offering of common stock at a public offering price of $3.30 per share.
  • Kartoon Studios Inc (NASDAQ:TOON) fell 25.3% to $1.1050 as the company announced pricing of up to $7 million registered direct offering of common stock.
  • INVO Bioscience, Inc. (NASDAQ:INVO) declined 24.4% to $1.3750. INVO BioScience recently reported a year-over-year increase in fourth-quarter revenue results.
  • Windtree Therapeutics, Inc. (NASDAQ:WINT) fell 24.4% to $0.2994. Windtree Therapeutics announced a 1-for-18 reverse stock split effective April 22.
  • NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) fell 24.1% to $3.17. NRx Pharmaceuticals announced pricing of $2 million underwritten public offering of common stock at a public offering price of $3.30 per share.
  • WiSA Technologies, Inc. (NASDAQ:WISA) fell 24.2% to $7.01.
  • SolarMax Technology, Inc. (NASDAQ:SMXT) dipped 11.2% to $8.53. SolarMax Technology recently reported fiscal year 2023 results.
  • Ocular Therapeutix, Inc. (NASDAQ:OCUL) fell 10.5% to $6.79. Ocular Therapeutix reported topline Phase 1 data for AXPAXLI in diabetic retinopathy.
  • Primerica, Inc. (NYSE:PRI) fell 8.6% to $193.38 following a report from The Bear Cave.
  • Synovus Financial Corp. (NYSE:SNV) shares declined 6.7% to $34.17 as the company posted weaker-than-expected results for its first quarter.
  • Equifax Inc. (NYSE:EFX) fell 6.2% to $223.07 after the company reported worse-than-expected first-quarter sales results and issued adjusted guidance below estimates.
  • Snap-on Incorporated (NYSE:SNA) shares fell 5.5% to $267.96 following weak quarterly sales.

Now Read This: How To Earn $500 A Month From Ford Stock Ahead Of Q1 Earnings Report

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment